Managing Jeopardy of Pulmonary Hypertension

Idiopathic pulmonary hypertension, for which the cause is unknown, is more common in young adults and is approximately twice as common in women as in men. One third of patients with left heart failure have pulmonary hypertension. The annual mortality rate for pulmonary hypertension is 15%. Therapeutic options for the patient with PAH continue to expand through basic discovery and controlled clinical trials. Recent advancements in PAH-are targeted therapies and interventional-surgical procedures which contribute to improvement in quality of life and survival.